These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 32842835)
21. Randomized trial of intravenous immunoglobulin maintenance treatment regimens in chronic inflammatory demyelinating polyradiculoneuropathy. Kuitwaard K; Brusse E; Jacobs BC; Vrancken AFJE; Eftimov F; Notermans NC; van der Kooi AJ; Fokkink WR; Nieboer D; Lingsma HF; Merkies ISJ; van Doorn PA Eur J Neurol; 2021 Jan; 28(1):286-296. PubMed ID: 32876962 [TBL] [Abstract][Full Text] [Related]
22. The role of IVIg in autoimmune neuropathies: the latest evidence. Hughes R J Neurol; 2008 Jul; 255 Suppl 3():7-11. PubMed ID: 18685920 [TBL] [Abstract][Full Text] [Related]
23. Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial. Gorson KC; Natarajan N; Ropper AH; Weinstein R Muscle Nerve; 2007 Jan; 35(1):66-9. PubMed ID: 16967492 [TBL] [Abstract][Full Text] [Related]
24. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial. van Schaik IN; van Geloven N; Bril V; Hartung HP; Lewis RA; Sobue G; Lawo JP; Mielke O; Cornblath DR; Merkies IS; Trials; 2016 Jul; 17(1):345. PubMed ID: 27455854 [TBL] [Abstract][Full Text] [Related]
25. Improvement of hemoglobin levels after a switch from intravenous to subcutaneous administration of immunoglobulin in chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy. Markvardsen LH; Christiansen I; Jakobsen J Transfusion; 2016 Oct; 56(10):2443-2448. PubMed ID: 27401495 [TBL] [Abstract][Full Text] [Related]
26. Changes in axonal and clinical function during intravenous and subcutaneous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy. Hansen PN; Mohammed AA; Markvardsen LK; Andersen H; Tankisi H; Sindrup SH; Krøigård T J Peripher Nerv Syst; 2023 Sep; 28(3):425-435. PubMed ID: 37212187 [TBL] [Abstract][Full Text] [Related]
27. CIDP prognosis in patients with IVIG treatment-related fluctuations. Cook M; Pasnoor M; Ajroud-Driss S; Brannagan TH; Dimachkie MM; Allen JA Muscle Nerve; 2023 Jan; 67(1):69-73. PubMed ID: 36330716 [TBL] [Abstract][Full Text] [Related]
28. Protocol of a dose response trial of IV immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy (DRIP study). Kuitwaard K; Fokkink WR; Brusse E; Vrancken AFJE; Eftimov F; Notermans NC; van der Kooi AJ; Merkies ISJ; Jacobs BC; van Doorn PA J Peripher Nerv Syst; 2018 Mar; 23(1):5-10. PubMed ID: 29119642 [TBL] [Abstract][Full Text] [Related]
29. Alemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathy. Marsh EA; Hirst CL; Llewelyn JG; Cossburn MD; Reilly MM; Krishnan A; Doran M; Ryan AM; Coles AJ; Jones JL; Robertson NP J Neurol; 2010 Jun; 257(6):913-9. PubMed ID: 20049473 [TBL] [Abstract][Full Text] [Related]
31. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy, a time to start and a time to stop. Adrichem ME; Eftimov F; van Schaik IN J Peripher Nerv Syst; 2016 Sep; 21(3):121-7. PubMed ID: 27241239 [TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies. Merkies ISJ; van Schaik IN; Léger JM; Bril V; van Geloven N; Hartung HP; Lewis RA; Sobue G; Lawo JP; Durn BL; Cornblath DR; De Bleecker JL; Sommer C; Robberecht W; Saarela M; Kamienowski J; Stelmasiak Z; Tackenberg B; Mielke O; J Peripher Nerv Syst; 2019 Mar; 24(1):48-55. PubMed ID: 30672091 [TBL] [Abstract][Full Text] [Related]
39. Hyaluronidase-facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: The ADVANCE-CIDP 1 randomized controlled trial. Bril V; Hadden RDM; Brannagan TH; Bar M; Chroni E; Rejdak K; Rivero A; Andersen H; Latov N; Levine T; Pasnoor M; Sacconi S; Souayah N; Anderson-Smits C; Duff K; Greco E; Hasan S; Li Z; Yel L; Ay H J Peripher Nerv Syst; 2023 Sep; 28(3):436-449. PubMed ID: 37314318 [TBL] [Abstract][Full Text] [Related]
40. Utility of somatosensory evoked potentials in the assessment of response to IVIG in a long-lasting case of chronic immune sensory polyradiculopathy. Clerici AM; Nobile-Orazio E; Mauri M; Squellati FS; Bono GG BMC Neurol; 2017 Jul; 17(1):127. PubMed ID: 28668085 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]